Stella Diagnostics, Inc. (OTCPK: SLDX)
Health Care · Health Care Providers & Services · US
$—
— today · — 1Y
Stella Diagnostics, Inc. (OTCPK: SLDX) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $2.43M and employs 2 people.
trading between 0.01 and 0.05.
Tweenvest scores Stella Diagnostics, Inc. across four factors: quality 13/100, value 24/100. Its strongest factor is value.
SLDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.43M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -7.53
- Dividend yield
- —
- Beta (5Y)
- -0.21
- 52-week high
- $0.05
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 301.51M
- Employees
- 2
- Next earnings
- —
About Stella Diagnostics, Inc.
Stella Diagnostics Inc. is a molecular diagnostics firm primarily focused on advancing patient care strategies for individuals afflicted with severe esophageal disorders. The company's specialized clinical tests furnish physicians with crucial information regarding the molecular makeup of a patient's tissue, enabling them to ascertain if the disease is static, deteriorating, or undergoing malignant transformation. Additionally, Stella Diagnostics is engaged in the development of innovative diagnostic tools intended to provide healthcare professionals with enhanced molecular insights compared to conventional screening methods. The organization rebranded from its previous identity, JMP Properties, Inc., to Stella Diagnostics, Inc. in April 2021 and is based in Salt Lake City, Utah.
- ISIN
- US85853Y1047
- Listed since
- Apr 16, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $390.11 | +1.37% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.02 | -0.67% |
| McKesson CorporationNYSE: MCK | $100.14B | $858.90 | +2.40% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.19 | +5.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $400.54 | +1.07% |
| The Cigna GroupNYSE: CI | $73.33B | $277.51 | +1.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $318.04 | +1.06% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.51 | +0.46% |
Figures last refreshed Aug 18, 2026.